Treating Disease with Neurotechnology | Oscillo Biosciences
We are developing medical devices and digital therapeutic platforms that offer hope to those suffering from neurodegenerative diseases like Alzheimer’s disease, Parkinson’s, aphasia, dyslexia and others.
Overview
Oscillo Biosciences is a pre-commercial neurotechnology company based in Hartford, Connecticut. The company develops medical devices and digital therapeutic platforms aimed at treating neurodegenerative diseases such as Alzheimer’s disease and Parkinson’s disease. Oscillo Biosciences has created a non-invasive intervention that utilizes brain stimulation through self-selected music and synchronized light rhythms. Its patented software synchronizes light pulses with music to rhythmically stimulate the brain at specific frequencies. This method targets endogenous theta and gamma oscillations, which helps restore healthy brain rhythms, enhance memory, and preserve cognition in adults with Mild Cognitive Impairment and Alzheimer’s disease.
Details
- Category
- Biotechnology Research
- Headquarters
- Hartford, Connecticut
- Type
- Privately Held
- Founded
- 2017
- Followers
- 388
- Specialties
- Digital Therapeutics, Human Auditory Neuroscience, Signal Processing, Music Perception and Cognition, Music Technology, Neural Networks, Medical Device, Alzheimer's Disease, Neuroscience, Neurotech, Neurotechnology, Parkinson's Disease, Neuroplasticity, Neurostimulation, Healthy Aging, Optogenetics, Neuromodulation, Biotech, Biotechnology, and Brain Stimulation
- Locations
- Hartford, Connecticut, US
Austin, TX, US